| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 33 | 2021 | 620 | 4.620 |
Why?
|
| Cryosurgery | 12 | 2021 | 167 | 2.600 |
Why?
|
| Kidney Neoplasms | 31 | 2022 | 3022 | 2.580 |
Why?
|
| Carcinoma, Renal Cell | 21 | 2022 | 2326 | 2.090 |
Why?
|
| Surgery, Computer-Assisted | 8 | 2020 | 255 | 1.950 |
Why?
|
| Radiography, Interventional | 17 | 2018 | 306 | 1.380 |
Why?
|
| Ablation Techniques | 7 | 2021 | 148 | 1.330 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 3 | 2018 | 97 | 0.990 |
Why?
|
| Chemoembolization, Therapeutic | 10 | 2011 | 181 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 42 | 2016 | 7551 | 0.900 |
Why?
|
| Laser Therapy | 3 | 2011 | 411 | 0.830 |
Why?
|
| Liver Neoplasms | 25 | 2022 | 4557 | 0.780 |
Why?
|
| Microwaves | 1 | 2020 | 32 | 0.740 |
Why?
|
| Biopsy, Needle | 14 | 2016 | 1363 | 0.740 |
Why?
|
| Image-Guided Biopsy | 5 | 2018 | 327 | 0.700 |
Why?
|
| Electroporation | 1 | 2020 | 126 | 0.700 |
Why?
|
| Embolization, Therapeutic | 13 | 2020 | 551 | 0.700 |
Why?
|
| Bone Neoplasms | 8 | 2017 | 2576 | 0.670 |
Why?
|
| Renal Artery | 4 | 2016 | 79 | 0.650 |
Why?
|
| Hepatic Artery | 8 | 2011 | 240 | 0.640 |
Why?
|
| Diagnostic Imaging | 4 | 2021 | 1162 | 0.630 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 81 | 0.600 |
Why?
|
| Nephrectomy | 9 | 2018 | 779 | 0.590 |
Why?
|
| Treatment Outcome | 48 | 2021 | 32856 | 0.570 |
Why?
|
| Neoplasms, Second Primary | 3 | 2021 | 1350 | 0.530 |
Why?
|
| Postoperative Complications | 12 | 2021 | 5544 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2013 | 7704 | 0.510 |
Why?
|
| Radiology, Interventional | 2 | 2015 | 138 | 0.510 |
Why?
|
| Kidney | 7 | 2021 | 2146 | 0.490 |
Why?
|
| Lung Neoplasms | 12 | 2021 | 11538 | 0.490 |
Why?
|
| Ultrasonography, Interventional | 6 | 2008 | 429 | 0.440 |
Why?
|
| Muscle Neoplasms | 2 | 2011 | 109 | 0.440 |
Why?
|
| Chyle | 1 | 2011 | 10 | 0.400 |
Why?
|
| Hepatectomy | 6 | 2020 | 1011 | 0.390 |
Why?
|
| Humans | 109 | 2022 | 261584 | 0.380 |
Why?
|
| Osteotomy | 1 | 2011 | 100 | 0.370 |
Why?
|
| Mediastinal Diseases | 2 | 2008 | 56 | 0.370 |
Why?
|
| Chest Tubes | 4 | 2016 | 101 | 0.350 |
Why?
|
| Pneumothorax | 5 | 2016 | 153 | 0.350 |
Why?
|
| Thermography | 1 | 2010 | 59 | 0.350 |
Why?
|
| Aged, 80 and over | 32 | 2021 | 29903 | 0.350 |
Why?
|
| Aged | 60 | 2021 | 70121 | 0.350 |
Why?
|
| Portal Vein | 5 | 2020 | 355 | 0.330 |
Why?
|
| Urinary Bladder | 2 | 2011 | 575 | 0.330 |
Why?
|
| Male | 74 | 2022 | 123006 | 0.320 |
Why?
|
| Middle Aged | 64 | 2021 | 86218 | 0.320 |
Why?
|
| Pleural Diseases | 1 | 2008 | 57 | 0.320 |
Why?
|
| Precision Medicine | 1 | 2015 | 1154 | 0.320 |
Why?
|
| Blood Pressure | 1 | 2014 | 1468 | 0.310 |
Why?
|
| Intracranial Embolism | 1 | 2007 | 39 | 0.300 |
Why?
|
| Cytodiagnosis | 1 | 2008 | 220 | 0.300 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2018 | 502 | 0.290 |
Why?
|
| Female | 69 | 2022 | 142008 | 0.290 |
Why?
|
| Retrospective Studies | 43 | 2021 | 37920 | 0.280 |
Why?
|
| Neoplasms, Experimental | 1 | 2010 | 750 | 0.280 |
Why?
|
| Lung Diseases | 2 | 2010 | 717 | 0.280 |
Why?
|
| Laparoscopy | 2 | 2014 | 1229 | 0.270 |
Why?
|
| Pneumothorax, Artificial | 1 | 2005 | 4 | 0.270 |
Why?
|
| Biopsy | 5 | 2021 | 3445 | 0.270 |
Why?
|
| Adult | 52 | 2021 | 77987 | 0.270 |
Why?
|
| Pulmonary Embolism | 4 | 2019 | 329 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 341 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2018 | 10035 | 0.250 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 3578 | 0.250 |
Why?
|
| Aorta, Thoracic | 3 | 1999 | 546 | 0.250 |
Why?
|
| Osteoma, Osteoid | 1 | 2004 | 22 | 0.250 |
Why?
|
| Hypertension | 1 | 2014 | 1505 | 0.250 |
Why?
|
| Needles | 3 | 2015 | 107 | 0.240 |
Why?
|
| Catheters, Indwelling | 3 | 2018 | 374 | 0.230 |
Why?
|
| Hot Temperature | 1 | 2004 | 281 | 0.230 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2018 | 115 | 0.230 |
Why?
|
| Lung | 4 | 2021 | 3152 | 0.210 |
Why?
|
| Sarcoma | 1 | 2013 | 1726 | 0.210 |
Why?
|
| Dogs | 4 | 2010 | 1155 | 0.210 |
Why?
|
| Survival Rate | 12 | 2021 | 12221 | 0.200 |
Why?
|
| Vena Cava Filters | 2 | 2017 | 88 | 0.200 |
Why?
|
| Disease Models, Animal | 4 | 2010 | 7226 | 0.200 |
Why?
|
| Aneurysm, False | 3 | 2016 | 153 | 0.200 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2021 | 36 | 0.200 |
Why?
|
| Patient Selection | 6 | 2016 | 2056 | 0.200 |
Why?
|
| Neoplasms | 6 | 2017 | 15193 | 0.200 |
Why?
|
| Aortography | 2 | 1999 | 181 | 0.180 |
Why?
|
| Thorax | 1 | 2021 | 213 | 0.180 |
Why?
|
| Tumor Burden | 4 | 2020 | 1988 | 0.180 |
Why?
|
| Hepatic Veins | 1 | 2020 | 58 | 0.180 |
Why?
|
| Aortic Rupture | 2 | 1999 | 113 | 0.180 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 1085 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 2 | 1999 | 303 | 0.170 |
Why?
|
| Ultrasonography | 2 | 2005 | 1863 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 2404 | 0.170 |
Why?
|
| Societies, Medical | 2 | 2015 | 1335 | 0.160 |
Why?
|
| Musculoskeletal System | 1 | 2018 | 35 | 0.160 |
Why?
|
| Thoracic Injuries | 1 | 1998 | 58 | 0.160 |
Why?
|
| Liver | 5 | 2020 | 2961 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2008 | 2027 | 0.160 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1997 | 16 | 0.150 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 657 | 0.150 |
Why?
|
| Colon, Descending | 1 | 2017 | 6 | 0.150 |
Why?
|
| Colon, Ascending | 1 | 2017 | 12 | 0.150 |
Why?
|
| Osteosarcoma | 1 | 2004 | 929 | 0.150 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2004 | 882 | 0.150 |
Why?
|
| Intussusception | 1 | 1997 | 52 | 0.150 |
Why?
|
| Colonic Diseases | 1 | 1997 | 71 | 0.150 |
Why?
|
| Risk Factors | 9 | 2020 | 17529 | 0.140 |
Why?
|
| Indazoles | 2 | 2018 | 297 | 0.140 |
Why?
|
| Stents | 5 | 2021 | 1096 | 0.140 |
Why?
|
| Jejunostomy | 1 | 2016 | 52 | 0.140 |
Why?
|
| Portacaval Shunt, Surgical | 3 | 2005 | 6 | 0.140 |
Why?
|
| Liver Abscess | 1 | 2016 | 36 | 0.140 |
Why?
|
| Hydrogels | 1 | 2016 | 123 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2014 | 712 | 0.140 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 4972 | 0.140 |
Why?
|
| Equipment Design | 4 | 2016 | 1204 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 2595 | 0.130 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2009 | 297 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1997 | 176 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2013 | 1530 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2022 | 1248 | 0.130 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 354 | 0.130 |
Why?
|
| Metastasectomy | 1 | 2016 | 200 | 0.120 |
Why?
|
| Feasibility Studies | 5 | 2010 | 2293 | 0.120 |
Why?
|
| Sympathectomy | 1 | 2014 | 14 | 0.120 |
Why?
|
| Urinary Fistula | 2 | 2004 | 27 | 0.120 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 183 | 0.120 |
Why?
|
| Yttrium Radioisotopes | 2 | 2005 | 178 | 0.120 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2004 | 27 | 0.120 |
Why?
|
| Consensus | 2 | 2019 | 978 | 0.120 |
Why?
|
| Antineoplastic Agents | 6 | 2014 | 14290 | 0.120 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2007 | 112 | 0.120 |
Why?
|
| Genes, ras | 1 | 2017 | 667 | 0.120 |
Why?
|
| Urologic Diseases | 1 | 2014 | 78 | 0.120 |
Why?
|
| Cisplatin | 4 | 2004 | 2432 | 0.120 |
Why?
|
| Hemostatics | 1 | 2014 | 88 | 0.110 |
Why?
|
| Leukemia, Myeloid | 1 | 1998 | 941 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 6009 | 0.110 |
Why?
|
| Computer Systems | 1 | 2013 | 106 | 0.110 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 210 | 0.110 |
Why?
|
| Mitomycin | 2 | 2004 | 208 | 0.110 |
Why?
|
| Combined Modality Therapy | 5 | 2021 | 8865 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 335 | 0.110 |
Why?
|
| Pyelonephritis | 1 | 2012 | 39 | 0.110 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 14893 | 0.110 |
Why?
|
| Doxorubicin | 3 | 2004 | 3005 | 0.110 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2012 | 55 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2014 | 587 | 0.110 |
Why?
|
| Urologic Neoplasms | 1 | 2014 | 188 | 0.110 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2012 | 60 | 0.110 |
Why?
|
| Carcinoid Tumor | 2 | 2005 | 280 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2018 | 3518 | 0.100 |
Why?
|
| Pelvic Neoplasms | 2 | 2004 | 189 | 0.100 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2013 | 169 | 0.100 |
Why?
|
| Online Systems | 1 | 2011 | 27 | 0.100 |
Why?
|
| Radiography | 6 | 2005 | 1905 | 0.100 |
Why?
|
| Adolescent | 13 | 2015 | 31268 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2009 | 600 | 0.100 |
Why?
|
| Time Factors | 7 | 2018 | 12930 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 2 | 2020 | 402 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 396 | 0.100 |
Why?
|
| Urine | 1 | 2011 | 143 | 0.100 |
Why?
|
| Risk Management | 1 | 2011 | 107 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 3251 | 0.090 |
Why?
|
| Salvage Therapy | 2 | 2018 | 2054 | 0.090 |
Why?
|
| Kidney Function Tests | 4 | 2015 | 192 | 0.090 |
Why?
|
| Fluoroscopy | 3 | 2008 | 232 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2011 | 220 | 0.090 |
Why?
|
| Texas | 4 | 2018 | 6314 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2011 | 286 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2018 | 1823 | 0.090 |
Why?
|
| Prognosis | 7 | 2017 | 21714 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 329 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2018 | 1330 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 1390 | 0.080 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1202 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 322 | 0.080 |
Why?
|
| Imidazoles | 1 | 2014 | 1005 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 247 | 0.080 |
Why?
|
| Hyperthermia, Induced | 1 | 2013 | 510 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2021 | 2805 | 0.080 |
Why?
|
| Ureteral Diseases | 2 | 2004 | 16 | 0.080 |
Why?
|
| Pain Management | 2 | 2012 | 668 | 0.080 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 2 | 2004 | 22 | 0.080 |
Why?
|
| Renal Dialysis | 2 | 2007 | 945 | 0.080 |
Why?
|
| Disease-Free Survival | 6 | 2020 | 10001 | 0.080 |
Why?
|
| Kyphosis | 2 | 2004 | 43 | 0.080 |
Why?
|
| Bone Cements | 2 | 2004 | 45 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 60 | 0.080 |
Why?
|
| Pneumonectomy | 1 | 2013 | 831 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2019 | 6873 | 0.070 |
Why?
|
| Adenoviridae | 2 | 2003 | 1459 | 0.070 |
Why?
|
| Splenic Neoplasms | 1 | 2008 | 119 | 0.070 |
Why?
|
| Disease Management | 1 | 2013 | 1052 | 0.070 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 91 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2007 | 100 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 71 | 0.070 |
Why?
|
| Thrombin | 1 | 2007 | 99 | 0.070 |
Why?
|
| Angioplasty | 1 | 2007 | 94 | 0.070 |
Why?
|
| Palliative Care | 4 | 2021 | 2037 | 0.070 |
Why?
|
| Hepatic Encephalopathy | 2 | 2004 | 66 | 0.070 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2010 | 123 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2014 | 806 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 586 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2010 | 739 | 0.070 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2005 | 35 | 0.070 |
Why?
|
| Venereal Tumors, Veterinary | 1 | 2005 | 8 | 0.070 |
Why?
|
| Splenic Artery | 1 | 2005 | 50 | 0.070 |
Why?
|
| Splenic Diseases | 1 | 2005 | 56 | 0.070 |
Why?
|
| Hematologic Neoplasms | 2 | 2010 | 1870 | 0.070 |
Why?
|
| Electrodes | 1 | 2005 | 116 | 0.070 |
Why?
|
| Carcinoma | 1 | 2017 | 2578 | 0.060 |
Why?
|
| Leg Bones | 1 | 2004 | 11 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2005 | 412 | 0.060 |
Why?
|
| Dog Diseases | 1 | 2005 | 73 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5319 | 0.060 |
Why?
|
| Radius | 1 | 2004 | 42 | 0.060 |
Why?
|
| Humerus | 1 | 2004 | 53 | 0.060 |
Why?
|
| Outpatients | 1 | 2007 | 462 | 0.060 |
Why?
|
| HT29 Cells | 1 | 2004 | 159 | 0.060 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2006 | 192 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2008 | 690 | 0.060 |
Why?
|
| Drug Carriers | 1 | 2005 | 327 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2020 | 162 | 0.060 |
Why?
|
| Animals | 10 | 2010 | 59546 | 0.060 |
Why?
|
| Vascular Fistula | 1 | 2004 | 41 | 0.060 |
Why?
|
| Logistic Models | 1 | 2011 | 3442 | 0.060 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2003 | 34 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2004 | 155 | 0.060 |
Why?
|
| Child | 8 | 2015 | 29157 | 0.060 |
Why?
|
| Melanoma | 2 | 2011 | 5317 | 0.060 |
Why?
|
| Young Adult | 4 | 2021 | 21452 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2995 | 0.060 |
Why?
|
| Spleen | 1 | 2005 | 677 | 0.060 |
Why?
|
| Swine | 5 | 2007 | 1541 | 0.060 |
Why?
|
| Research Design | 1 | 2010 | 1544 | 0.060 |
Why?
|
| Radiography, Abdominal | 1 | 2004 | 120 | 0.060 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2007 | 690 | 0.060 |
Why?
|
| Spine | 1 | 2004 | 293 | 0.060 |
Why?
|
| Femoral Vein | 1 | 2003 | 66 | 0.060 |
Why?
|
| Bandages | 1 | 2003 | 71 | 0.060 |
Why?
|
| Back Pain | 1 | 2003 | 61 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2014 | 3890 | 0.050 |
Why?
|
| Steel | 1 | 2021 | 10 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 462 | 0.050 |
Why?
|
| Pelvis | 1 | 2003 | 363 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 245 | 0.050 |
Why?
|
| Spinal Fractures | 1 | 2003 | 132 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2017 | 15862 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 423 | 0.050 |
Why?
|
| Quality of Life | 3 | 2018 | 4532 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 726 | 0.050 |
Why?
|
| Pancreatic Diseases | 1 | 2002 | 108 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 384 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 4975 | 0.050 |
Why?
|
| Liver Diseases | 2 | 2004 | 574 | 0.050 |
Why?
|
| Pain | 2 | 2012 | 1658 | 0.050 |
Why?
|
| Microspheres | 3 | 2005 | 210 | 0.050 |
Why?
|
| Piperazines | 1 | 2009 | 2101 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 705 | 0.050 |
Why?
|
| Viral Vaccines | 1 | 2003 | 304 | 0.050 |
Why?
|
| Incidence | 3 | 2017 | 5674 | 0.050 |
Why?
|
| Anilides | 1 | 2022 | 268 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2006 | 634 | 0.050 |
Why?
|
| Disease Progression | 3 | 2018 | 6682 | 0.040 |
Why?
|
| Survival Analysis | 4 | 2017 | 9180 | 0.040 |
Why?
|
| Lymphoma | 1 | 2008 | 1467 | 0.040 |
Why?
|
| Retreatment | 1 | 2020 | 452 | 0.040 |
Why?
|
| Rupture | 1 | 1998 | 61 | 0.040 |
Why?
|
| Multidetector Computed Tomography | 1 | 2020 | 150 | 0.040 |
Why?
|
| Cryotherapy | 1 | 2018 | 67 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 2009 | 254 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2003 | 1090 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 4757 | 0.040 |
Why?
|
| Cost Control | 1 | 2018 | 48 | 0.040 |
Why?
|
| Models, Animal | 3 | 2007 | 664 | 0.040 |
Why?
|
| Cecal Diseases | 1 | 1997 | 13 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 846 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2007 | 76 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 4745 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 1998 | 231 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 209 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1999 | 137 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 5395 | 0.040 |
Why?
|
| Mutation | 1 | 2017 | 15179 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 5767 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 1270 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 5112 | 0.030 |
Why?
|
| Patient Safety | 1 | 2021 | 650 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5178 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2007 | 118 | 0.030 |
Why?
|
| Ultrasonography, Mammary | 1 | 1998 | 380 | 0.030 |
Why?
|
| Arthralgia | 1 | 2016 | 89 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 4988 | 0.030 |
Why?
|
| Renal Veins | 2 | 2007 | 56 | 0.030 |
Why?
|
| Margins of Excision | 1 | 2017 | 285 | 0.030 |
Why?
|
| Pyridines | 1 | 2022 | 1244 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 13658 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 297 | 0.030 |
Why?
|
| Thoracic Surgical Procedures | 1 | 1998 | 261 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 1997 | 369 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 371 | 0.030 |
Why?
|
| Safety | 2 | 2007 | 465 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 4654 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 9246 | 0.030 |
Why?
|
| Hypertension, Portal | 2 | 2005 | 124 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 1998 | 15694 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 750 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 2422 | 0.030 |
Why?
|
| Recurrence | 2 | 2003 | 4759 | 0.030 |
Why?
|
| Vascular Patency | 2 | 2005 | 218 | 0.030 |
Why?
|
| Contrast Media | 1 | 2020 | 1472 | 0.030 |
Why?
|
| Medical Records | 2 | 2005 | 415 | 0.030 |
Why?
|
| Urothelium | 1 | 2014 | 254 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 795 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 208 | 0.030 |
Why?
|
| ras Proteins | 1 | 2017 | 770 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1998 | 655 | 0.030 |
Why?
|
| Diarrhea | 1 | 2016 | 686 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1249 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6207 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 3976 | 0.030 |
Why?
|
| Prosthesis Design | 2 | 2005 | 749 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2018 | 12878 | 0.020 |
Why?
|
| Systems Integration | 1 | 2011 | 76 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2864 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2003 | 2138 | 0.020 |
Why?
|
| Algorithms | 2 | 2017 | 3890 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2018 | 852 | 0.020 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2010 | 17 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 3552 | 0.020 |
Why?
|
| United States | 2 | 2018 | 15439 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 2315 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2010 | 68 | 0.020 |
Why?
|
| Health Services Research | 1 | 2011 | 233 | 0.020 |
Why?
|
| Lung Diseases, Fungal | 1 | 2010 | 124 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 4300 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 323 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 544 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 313 | 0.020 |
Why?
|
| Nephrons | 1 | 2008 | 48 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 4849 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 3475 | 0.020 |
Why?
|
| Radiotherapy Dosage | 2 | 2005 | 3842 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 4844 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2010 | 247 | 0.020 |
Why?
|
| Auscultation | 1 | 2007 | 10 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2007 | 164 | 0.020 |
Why?
|
| Medical Audit | 1 | 2008 | 188 | 0.020 |
Why?
|
| Radiotherapy | 2 | 2005 | 1824 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2007 | 316 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 602 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 360 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 698 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2009 | 1665 | 0.020 |
Why?
|
| Portal Pressure | 1 | 2005 | 13 | 0.020 |
Why?
|
| Polyvinyl Alcohol | 1 | 2005 | 19 | 0.020 |
Why?
|
| Urinary Bladder Fistula | 1 | 2004 | 13 | 0.020 |
Why?
|
| Genetic Therapy | 2 | 2003 | 1616 | 0.020 |
Why?
|
| Aneurysm | 1 | 2005 | 94 | 0.020 |
Why?
|
| Gelatin | 1 | 2005 | 49 | 0.020 |
Why?
|
| Acrylic Resins | 1 | 2005 | 43 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 1101 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2005 | 222 | 0.020 |
Why?
|
| Phlebography | 1 | 2005 | 76 | 0.020 |
Why?
|
| Hematocrit | 1 | 2005 | 142 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 1324 | 0.020 |
Why?
|
| Urethral Diseases | 1 | 2004 | 36 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2005 | 117 | 0.020 |
Why?
|
| Hydrothorax | 1 | 2004 | 18 | 0.020 |
Why?
|
| Ethanol | 1 | 2006 | 264 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2005 | 133 | 0.020 |
Why?
|
| Varicose Veins | 1 | 2004 | 35 | 0.020 |
Why?
|
| Benzamides | 1 | 2009 | 1832 | 0.020 |
Why?
|
| Ilium | 1 | 2004 | 54 | 0.010 |
Why?
|
| Floxuridine | 1 | 2003 | 38 | 0.010 |
Why?
|
| Osteolysis | 1 | 2004 | 80 | 0.010 |
Why?
|
| Hemoperitoneum | 1 | 2003 | 12 | 0.010 |
Why?
|
| Ascites | 1 | 2004 | 198 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2005 | 558 | 0.010 |
Why?
|
| Wounds, Penetrating | 1 | 2004 | 89 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2003 | 40 | 0.010 |
Why?
|
| Reoperation | 1 | 2007 | 1382 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2003 | 171 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2005 | 477 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2003 | 107 | 0.010 |
Why?
|
| Immobilization | 1 | 2003 | 93 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 2003 | 210 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2003 | 156 | 0.010 |
Why?
|
| Contraindications | 1 | 2002 | 150 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 164 | 0.010 |
Why?
|
| Vinblastine | 1 | 2003 | 453 | 0.010 |
Why?
|
| Hemostasis | 1 | 2003 | 110 | 0.010 |
Why?
|
| Fractures, Spontaneous | 1 | 2003 | 84 | 0.010 |
Why?
|
| Leucovorin | 1 | 2003 | 332 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 980 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 1519 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 1756 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2003 | 202 | 0.010 |
Why?
|
| Platelet Count | 1 | 2003 | 490 | 0.010 |
Why?
|
| Body Height | 1 | 2003 | 231 | 0.010 |
Why?
|
| Cause of Death | 1 | 2005 | 753 | 0.010 |
Why?
|
| Endosonography | 1 | 2005 | 536 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 960 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2006 | 1656 | 0.010 |
Why?
|
| Thrombosis | 1 | 2007 | 781 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 2005 | 493 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 716 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2006 | 977 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2008 | 16273 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2007 | 1959 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2003 | 703 | 0.010 |
Why?
|
| Intestines | 1 | 2004 | 686 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 4893 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2003 | 1944 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1999 | 116 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 1901 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2006 | 1112 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2003 | 631 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 1694 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2010 | 2979 | 0.010 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2004 | 1415 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3639 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 3722 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 6150 | 0.010 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1999 | 595 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 5061 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7789 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 7591 | 0.010 |
Why?
|